AR005417A1 - Una composicion farmaceutica antitumoral sinergistica - Google Patents

Una composicion farmaceutica antitumoral sinergistica

Info

Publication number
AR005417A1
AR005417A1 ARP960102652A AR10265296A AR005417A1 AR 005417 A1 AR005417 A1 AR 005417A1 AR P960102652 A ARP960102652 A AR P960102652A AR 10265296 A AR10265296 A AR 10265296A AR 005417 A1 AR005417 A1 AR 005417A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
synergistic
antitumoral
antitumoral pharmaceutical
derivative
Prior art date
Application number
ARP960102652A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR005417A1 publication Critical patent/AR005417A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición farmacéutica antitumoral sinergística que comprende una cantidad efectiva de interleucina-12 y un derivado de pirimidina nucleósidocomo así también un hidrato o solvato del mismo que se convierte en fluorouracilo o suderivado, y un portador farmacéuticamente aceptable.
ARP960102652A 1995-05-26 1996-05-22 Una composicion farmaceutica antitumoral sinergistica AR005417A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95108063 1995-05-26

Publications (1)

Publication Number Publication Date
AR005417A1 true AR005417A1 (es) 1999-06-23

Family

ID=8219298

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102652A AR005417A1 (es) 1995-05-26 1996-05-22 Una composicion farmaceutica antitumoral sinergistica

Country Status (9)

Country Link
EP (1) EP0828508A2 (es)
JP (1) JPH10506641A (es)
CN (1) CN1184430A (es)
AR (1) AR005417A1 (es)
AU (1) AU5998296A (es)
BR (1) BR9608779A (es)
CA (1) CA2220837A1 (es)
TR (1) TR199701435T1 (es)
WO (1) WO1996037214A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents

Also Published As

Publication number Publication date
CN1184430A (zh) 1998-06-10
MX9708915A (es) 1998-03-31
WO1996037214A3 (en) 1997-01-09
CA2220837A1 (en) 1996-11-28
TR199701435T1 (xx) 1998-03-21
EP0828508A2 (en) 1998-03-18
WO1996037214A2 (en) 1996-11-28
BR9608779A (pt) 1999-07-06
AU5998296A (en) 1996-12-11
JPH10506641A (ja) 1998-06-30

Similar Documents

Publication Publication Date Title
LU91758I2 (fr) Denosumab et ses dérivés pharmaceutiquement acceptables (PROLIA®)
YU78291A (sh) 1,3-oksatiolanski nukleozidni analozi
LU90283I2 (fr) Sporanox soluté buvable et ses dérivés pharmaceutiquement acceptables
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
ES2175079T3 (es) Derivados de indol utiles como inhibidores de cgmp-pde.
NO950207L (no) Strekkbar absorberende gjenstand med mindre strekkbare barrierer
LU90769I2 (fr) Capecitabine et ses d-riv-es pharmaceutiquement acceptables (xeloda)
EA200100298A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5
ATE121735T1 (de) 2,4-diaminochinazolin-derivate, um die antitumorwirkung zu erhöhen.
KR870005637A (ko) 약물 데포
BG102600A (en) Carbamoyloxy derivatives of mutilin and their use as bactericides
RS49721B (sr) Kompozicija koja sadrži biljku i površinski aktivno sredstvo korisna u proizvodnji proizvoda za tretiranje herpesa i drugih mikrobnih infekcija
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
ATE137242T1 (de) Kovalente-ther lipidnukleosid-konjugate
BG103714A (en) Pararacetamol-containing tablet
ATE213937T1 (de) Spezielle halofantrinhaltige zusammensetzungen
ES2118087T3 (es) Composiciones inmunosupresoras.
HUT61765A (en) Process for producing purine nucleoside phosphorylase inhibitors and pharmaceutical compositions comprising same as active ingredient
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
AR005417A1 (es) Una composicion farmaceutica antitumoral sinergistica
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
IT1232819B (it) Impiego di sorgenti di nucleobasi per stimolare la funzione immunitaria, relativo procedimento e composizioni farmaceutiche contenenti una tale sorgente di nucleobasi
CO4930269A1 (es) Composiciones farmaceuticas
MX9203613A (es) Derivados de adenosina y composiciones farmaceuticas que los contienen.
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them